Multiresistant acinetobacter in the UK: How big a threat?

Journal of Hospital Infection

Volumn 58, Issue 3, 2004, Pages 167-169

  Coelho, Juliana ^a   Woodford, N ^a   Turton, J ^a   Livermore, D M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Gaussian source; Solar radiation; View factor

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; COLISTIN; DOXYCYCLINE; IMIPENEM; MEROPENEM; METICILLIN; MINOCYCLINE; PENICILLIN DERIVATIVE; POLYMYXIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULBACTAM; SULTAMICILLIN; TIGECYCLINE;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG USE; ENZYME ACTIVITY; EPIDEMIC; GRAM NEGATIVE INFECTION; HEALTH SURVEY; HOSPITAL HYGIENE; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; UNITED KINGDOM; WOUND INFECTION;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ANTI-INFECTIVE AGENTS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE; GREAT BRITAIN; HUMANS; INFECTION CONTROL;

EID: 7744235233     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2003.12.019     Document Type: Article

References (25)

1. Henwood C.J. Gatward T. Warner M. et al. Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936) J Antimicrob Chemother 49 2002 479-487
2. Corebella X. Montero A. Pujol M. et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii J Clin Microbiol 38 2000 4086-4095
3. Afzal-Shah M. Livermore D.M. Worldwide emergence of carbapenem-resistant Acinetobacter spp J Antimicrob Chemother 41 1998 576-577
4. Livermore D.M. The threat from the pink corner Ann Med 35 2003 226-234
5. Livermore D.M. The impact of carbapenemases on antimicrobial development and therapy Curr Opin Invest Drugs 3 2002 218-224
6. Bou G. Cervero G. Dominguez M.A. Quereda C. Martinez-Beltran J. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: High-level carbapenem resistance in A. baumannii is not due solely to the presence of β-lactamases J Clin Microbiol 38 2000 3299-3305
7. Fernadez-Cuenca F. Martinez-Martinez L. Conejo M.C. Ayala J.A. Perea E.J. Pascual A. Relationship between β-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii J Antimicrob Chemother 51 2003 565-574
8. Tysall L. Stockdale M.W. Chadwick P.R. et al. IMP-1 carbapenemase detected in an Acinetobacter clinical isolate from the UK J Antimicrob Chemother 49 2002 217-218
9. Towner K.J. Gee T. Boswell T. An unwanted import to the UK: A carbapenem-resistant clinical isolate of Acinetobacter baumannii producing metallo-β-lactamase J Antimicrob Chemother 50 2002 1092-1093
10. Chu Y.W. Afzal-Shah M. Houang E.T. et al. IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998 Antimicrob Agents Chemother 45 2001 710-714
11. Yum J.H. Yi K. Lee H. Yong D. et al. Molecular characterization of metallo-β-lactamase-producing Acinetobacter baumannii and genomospecies 3 from Korea: Identification of two new integrons carrying the bla (VIM-2) gene cassettes J Antimicrob Chemother 49 2002 837-840
12. Donald H.M. Scaife W. Amyes S.G. Young H.K. Sequence analysis of ARI-1, a novel OXA β-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92 Antimicrob Agents Chemother 44 2000 196-199
13. Dalla-Costa L.M. Coelho J.M. Souza H.A. et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil J Clin Microbiol 41 2003 3403-3406
14. Afzal-Shah M. Woodford N. Livermore D.M. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii Antimicrob Agents Chemother 45 2001 583-588
15. National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 5th edn Approved Standard M7-A5 2000 Wayne, PA NCCLS
16. MacGowan A.P. Wise R. Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests J Antimicrob Chemother 48 Suppl. 1 2001 17-28
17. Turton J.F. Kaufmann M.E. Warner M. Dijkshoorn L. Pitt T. A prevalent strain of Acinetobacter baumannii in Southeast England Proceedings and Abstracts of the 6th International Meeting on Microbial Epidemiological Markers 27-30 August 2003 Switzerland, Abstr. 153 p. 91
18. Anonymous. Acinetobacter spp. and Enterococcus spp. bacteraemia: England, Wales, and Northern Ireland, 2002. CDR Wkly 2003;13:4-12.
19. Coelho J.M. Turton J. Woodford N. Livermore D.M. Epidemiology of carbapenem-resistant Acinetobacter spp. in the UK Proceedings and Abstracts of the 43rd ICAAC, 2003 Chicago, 14-17 September 2003 147 Abstr. C2-1965
20. Morrison D. Woodford N. Cookson B. Enterococci as emerging pathogens of humans Soc Appl Bacteriol Symp Ser 26 Suppl. 1997 89S-99S
21. Das I. Lambert P. Hill D. Noy M. Bion J. Elliott T. Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units J Hosp Infect 50 2002 110-114
22. Podnos Y.D. Cinat M.E. Wilson S.E. Cooke J. Gormick W. Thrupp L.D. Eradication of multi-drug resistant acinetobacter from an intensive care unit Surg Infect (Larchmt) 2 2001 297-301
23. Rahal J.J. Urban C. Segal-Maurer S. Nosocomial antibiotic resistance in multiple Gram-negative species: Experience at one hospital with squeezing the resistance balloon at multiple sites Clin Infect Dis 34 2002 499-503
24. Levin A.S. Barone A.A. Penco J. et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii Clin Infects Dis 28 1999 1008-1011
25. Wood G.C. Hanes S.D. Croce M.A. Fabain T.C. Boucher B.A. Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia Clin Infect Dis 34 2002 1425-1430